ISSN (print) 1997-6933     ISSN (online) 2500-2139

Vol. 17 No. 2 (2024)

Published 1 April 2024
76-81
In Memory of Professor N.N. Tupitsyn
PDF (Russian)

EXPERIMENTAL STUDIES

Alena Igorevna Shakirova, I.N. Gaponenko, Ya.V. Komarova, O.S. Epifanovskaya, D.A. Senichkina, V.S. Sergeev, A.R. Muslimov, A.V. Onopchenko, E.V. Shchelina, S.A. Osipova, O.G. Bredneva, M.L. Vasyutina, Ya.G. Toropova, K.V. Lepik, M.O. Popova, I.S. Moiseev, A.D. Kulagin
82-93
Xenotransplantation of Human Hematopoietic Stem Cells into NBSGW Mice: A Basic Model for Preclinical Development of Gene Therapy Approaches
PDF_2024-17-2_82-93 (Russian)

REVIEWS

Sergei Vyacheslavovich Semochkin
94-108
Plasma Cell Tumors in Hematological Classifications of 2022: WHO-HAEM5 (WHO, 5th edition) and ICC (International Consensus Classification). A Clinician’s View
PDF_2024-17-2_94-108 (Russian)
Aleksei Sergeevich Subbotin, A.I. Pronin, T.M. Geliashvili, P.E. Tulin, T.S. Basova, B.M. Khakulova, G.S. Tumyan, A.A. Semenova
109-128
PET/CT in Hematological Malignancies: What Has Been Achieved and What Remains to Be Done
PDF_2024-17-2_109-128 (Russian)
Mariya Vladimirovna Melnikova, A.M. Kovrigina
129-140
Plasmablastic Lymphoma and Plasmablastic Myeloma: А Diagnostic Dilemma (Literature Review)
PDF_2024-17-2_129-140 (Russian)

LYMPHOID TUMORS

Yana Yurevna Shebunyaeva
141-153
The Role of Polymorphic Variants of Р450 Cytochrome Genes as well as Genes GSTP1 and MDR1 in Toxic Complications of Program Drug Chemotherapy for Classical Hodgkin Lymphoma
PDF_2024-17-2_141-153 (Russian)
Igor Alekseevich Olkhovskii
154-165
Diagnostic Potential of Regulatory Non-Coding Protein RNAs in Chronic Lymphocytic Leukemia
PDF_2024-17-2_154-165 (Russian)
Maksim Sergeevich Minaev
166-172
CD20-Positive B-Lymphocytes in the Reactive Tumor Microenvironment as an Independent Immunohistochemical Prognostic Factor in Nodular Sclerosis Classical Hodgkin Lymphoma
PDF_2024-17-2_166-172 (Russian)
Marat Albertovich Mingalimov
173-179
Therapy Optimization in Newly Diagnosed Diffuse Large B-Cell Lymphoma: Efficacy and Safety of the R-SD-EPOCH ± HDMTX Program Under Single-Center Non-Randomized Prospective Clinical Trial (Preliminary Results)
PDF_2024-17-2_173-179 (Russian)

MYELOID TUMORS

Vsevolod Gennadevich Potapenko, E.V. Morozova
180-194
Treatment of Aggressive Systemic Mastocytosis and Mast Cell Leukemia. Literature Review and Case Reports
PDF_2024-17-2_180-194 (Russian)

RARE HEMATOLOGICAL TUMORS AND SYNDROMES

Anna Leonidovna Neverova
195-203
Paroxysmal Nocturnal Hemoglobinuria and Primary Myelofibrosis as an Extremely Rare Combination of Clonal Hematological Diseases: A Literature Review and Two Clinical Case Reports
PDF_2024-17-2_195-203 (Russian)

CLINICAL TRIALS

Svetlana Vitalevna Shtyrkova, K.I. Danishyan, E.N. Parovichnikova
204-212
Risk Factors for Relapses of Perianal Infectious Complications in Patients with Hematological Malignancies: Results of a Single-Center Prospective Trial
PDF_2024-17-2_204-212 (Russian)

Supplement

III scientific-practical conference conference “Modern approaches to the diagnosis and treatment of hematological diseases”
Приложение (Russian)